Life Sciences R...'s  Instablog

Full Index of Posts 62 posts, page 1 of 2

• Two Biotech Ideas You May Have Missed: William Gregozeski

  Thu, May 16 • AHRO.OB, RHHBY.OB, SHPG

• Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert

  Fri, May 10 • ACTC.OB, ATHX, BTX

• Six Superstars For Your Biotech Portfolio: John McCamant

  Thu, May 9 • ALKS, CNDO, INCY

• Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential

  Thu, May 2 • AMRN, ALPMF.PK, BAYZF.PK

• Biotech Micro Caps Offer Promise Of Mighty Returns: Dick Huebner

  Thu, Apr 25 • ABT, AMGN, LFVN

• What Will It Take For Stem Cell Companies To Close The Valuation Gap?: ARM's Chairman Geoff MacKay

  Tue, Apr 16 • AMGN, ALPMF.PK, GE

• Companies That Can Mend The Biotech Market: Stephen Brozak

  Thu, Apr 11 • ASTM, ALXA, ATHX

• 6 Biotechs With Staggering Potential: Grant Zeng

  Thu, Apr 4 • ALNY, ATOS, BMY

• 7 Big Growth Stories In Biotech: Keith Markey

  Thu, Mar 28 • BDX, BCR, GSK

• Solving The R&D Investment Dilemma With Project Funding: Mark Kessel

  Thu, Mar 21 • ALXA, DVAX, LLY

• The Stem Cell Revolution Can Jump-Start Your Portfolio: Jason Kolbert

  Thu, Mar 14 • ASTM, ATHX, BTX

• 10 Biotech Stocks Poised To Run: George Zavoico

  Thu, Mar 7 • ACAD, AMGN, ARQL

• Regenerative Medicine Companies Are Hubs Of Future Profit: Gil Van Bokkelen

  Thu, Feb 28 • ASTM, AMGN, ATHX

• What Will Boost Medtech Stocks? Look For A Better Mousetrap, Says William Plovanic

  Thu, Feb 21 • DXCM, GMED, PODD

• Ram Selvaraju: Fall In Love With These Nine Biotech Stocks

  Thu, Feb 14 • ACHN, FRX, GALE

• Eight Biotech Growth Names: Greg Wade

  Thu, Feb 7 • ADDXF.PK, ANAC, BIIB

• The Life Sciences Report Watchlist 2013

  Thu, Jan 31 • AMRN, ARIA, CELG

• Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured

  Thu, Jan 24 • ASTM, AMGN, ATHX

• Anything For A Buck: Jim Letourneau Looks To Canadian Biotech For Opportunity

  Thu, Jan 17 • ABT, ACST, AMRN

• Which Six Companies Are In Michael King's Oncology Wheelhouse?

  Fri, Jan 11 • ALNY, AMGN, ARIA

• 2012: A Healthy Year For The Life Sciences

  Fri, Dec 28, 2012 • commodities

• Zacks Analyst Jason Napodano's Seven Biotech Picks Will Keep Your Profits On Solid Ground

  Thu, Dec 13, 2012 • ACAD, CBST, DEPO

• Ross Silver On How To Find The Perfect Combo Of Biotech Science And Market Savvy

  Thu, Dec 6, 2012 • ACFN, MSTX, ALGXY.OB

• Testing, Testing: Analyst Kevin DeGeeter On Five Good Bets In Cancer Diagnostics

  Thu, Nov 29, 2012 • CAH, EXAS, GHDX

• Applying The Venture Capital Model To Public Companies: Hugh Cleland

  Tue, Nov 20, 2012 • ACST, NPCUF.PK, AMRN

• Michael Berry Applies His 10 Discovery Investing Factors To Biotech

  Tue, Nov 20, 2012 • CELG, CDXC.OB, CUR

• Analyst Scott Power Finds The Upside In Biotech Down Under

  Thu, Nov 8, 2012 • ABT, ARUXF.PK, AEMAF.PK

• A Capital-Efficient Prescription For New Drugs: Raghuram "Ram" Selvaraju

  Thu, Nov 1, 2012 • IGXT.OB, BLRX, TEVA

• Out Of The Red And Into The Black: John McCamant On Investment In Blood Cancer Companies

  Thu, Oct 25, 2012 • AMGN, ASTX, CELG

• Casey Analyst Forecasts Explosive Biotech Growth

  Thu, Oct 11, 2012 • ALNY, CLSN, CRIS

• Pick Biotech Winners Like A Pro: John McCamant

  Thu, Oct 4, 2012 • Life Sciences, Cancer, Biotech

• Can Stem Cells Regenerate Your Portfolio? Stephen Dunn Says Yes

  Thu, Sep 27, 2012 • Life Sciences, Stem Cell, Healthcare

• Seven Innovative Biotechs That Could Soar By Year-End: George Zavoico

  Thu, Sep 13, 2012 • ASTM, ACAD, AGEN

• Top Medtech Analyst Points To Post-Obamacare Opportunities

  Thu, Sep 6, 2012 • Medical devices, orthopedics, Cardiology

• Analyst Bets On Extraordinary Science And Clinical Data: Greg Wade

  Thu, Aug 30, 2012 • Life Sciences, Biotech, Drug Discovery